$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Acute heart failure (AHF) is the most common cause of hospital admission in patients aged > 65 years, with congestion being the predominant symptom in the majority of cases as well as the main reason for hospitalization1. Heart failure (HF) can lead to malnutrition through different mechanisms, including malabsorption due to intestinal edema, hypercatabolism due to sustained neurohormonal activation, and constant inflammation2,3. Therefore, congestion and malnutrition directly influence body composition.
Bioelectrical impedance analysis (BIA) is a quick, noninvasive, and safe method that provides immediate bedside and reliable measurements to estimate body composition by introducing a constant low-level alternating electrical current that measures the impedance (Z) or resistance/opposition generated by human cells and tissues. The BIA involves two parameters: resistance (R) and reactance (Xc)4.
Additionally, it measures the delay between the current and voltage required to penetrate the cell membrane and tissue interfaces, known as the phase angle (PhA), which has been suggested to be an indicator of cellular health, cell membrane integrity, and vitality, which are affected by fluid distribution, inflammation, and malnutrition due to tissue resistivity and electrical properties. Lower PhA values indicate apoptosis and reduced components of the cellular matrix, whereas higher values reflect greater cellularity and better cell function5. Different studies have consistently demonstrated the prognostic role of PhA in multiple outcomes, such as mortality, rehospitalization, length of hospital stay, and risk of poor nutritional status in different clinical settings, including patients with HF6,7.
This study aimed to describe the steps for performing multivariable Cox regression analysis with penalized splines to determine the cutoff value of PhA by BIA in the first 24 h after admission to predict in-hospital mortality and all-cause mortality or rehospitalization following 90 day post discharge in patients with AHF.